PTC Therapeutics Inc Dividends

The next dividend date for PTC Therapeutics Inc has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for PTC Therapeutics Inc (PTCT)

No Results.
DateDeclaration DateRecord DatePayment DateAmount
No Results.

More About PTC Therapeutics Inc

Country
USA
Full Time Employees
939

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and inflammation and ferroptosis platforms, including vatiquinone to treat Friedreich's ataxia. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. The company has license and collaboration agreement with Novartis Pharmaceuticals Corporation to develop PTC518 Huntington's disease program. It markets Upstaza, a gene therapy with the brand name Kebilidi in the United States. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in Warren, New Jersey.

Owning PTC Therapeutics Inc Stock on the Dividend Date

If you own PTC Therapeutics Inc stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of PTC Therapeutics Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of PTC Therapeutics Inc stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying PTC Therapeutics Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the PTC Therapeutics Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More PTC Therapeutics Inc Dividends

You can contact us any time if you would like to ask questions about PTC Therapeutics Inc dividends or anything else related to the stock market.